In a large retrospective cohort study, GLP-1RAs significantly improve metabolic outcomes in individuals with MASLD, it can reduce major adverse cardiovascular events, all-cause mortality, and hospitalizations due to heart failure among individuals diagnosed with type 2 diabetes ( 2.3 Crosstalk between GLP-1 and and the gut microbiome 2.3.1 GLP-1 modulates the gut microbiota Emerging evidence indicates a bidirectional regulatory relationship between GLP-1RAs and the gut microbiota (Zhang et al., 2018
How is compounded semaglutide different from branded medications
Low costs Cost can be a big issue for people, especially since weight loss medications are often not covered by insurance
When you can show your provider that burps increase after certain foods or dose changes, those conversations become much more productive
Standing up an infrastructure to centrally collect PROs among hundreds of centers inevitably comes with unexpected obstacles, surprises, and learning lessons along the way
Do Any of the Trials (inc
